albuterol has been researched along with Cardiovascular Stroke in 21 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nine patients with critically reduced cardiac output after acute myocardial infarction underwent a single cross-over comparison of dobutamine and salbutamol to compare the haemodynamic effects of these drugs, which have, respectively, predominantly beta 1-adrenergic and beta 2-adrenergic agonist activity." | 9.05 | Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic shock after acute myocardial infarction. ( Chamberlain, DA; Crick, JP; Fowler, MB; Timmis, AD; Vincent, R, 1982) |
| "To report a case of acute myocardial infarction (AMI) following the use of albuterol (salbutamol) in a patient without preexisting coronary artery disease and to review the related literature." | 7.72 | Acute myocardial infarction associated with albuterol. ( Davis, MW; Fisher, AA; McGill, DA, 2004) |
| "Nine patients with critically reduced cardiac output after acute myocardial infarction underwent a single cross-over comparison of dobutamine and salbutamol to compare the haemodynamic effects of these drugs, which have, respectively, predominantly beta 1-adrenergic and beta 2-adrenergic agonist activity." | 5.05 | Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic shock after acute myocardial infarction. ( Chamberlain, DA; Crick, JP; Fowler, MB; Timmis, AD; Vincent, R, 1982) |
| " We describe an unusual case of a 47-year-old woman whose increased use of inhaled albuterol led to a non-ST-segment elevation myocardial infarction and unmasking of hemodynamically significant myocardial bridging." | 3.74 | Increased use of beta-agonists leading to non-ST-segment elevation myocardial infarction in a patient with hemodynamically significant myocardial bridging. ( Gold, DR; Makaryus, AN; Zolli, JR, 2008) |
| "To report a case of acute myocardial infarction (AMI) following the use of albuterol (salbutamol) in a patient without preexisting coronary artery disease and to review the related literature." | 3.72 | Acute myocardial infarction associated with albuterol. ( Davis, MW; Fisher, AA; McGill, DA, 2004) |
| "Although large surveys have documented the favourable safety profile of beta(2)-adrenoceptor agonists (beta(2)-agonists) and, above all, that of the long-acting agents, the presence in the literature of reports of adverse cardiovascular events in patients with obstructive airway disease must induce physicians to consider this eventuality." | 2.43 | Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. ( Cazzola, M; Donner, CF; Matera, MG, 2005) |
| "Salbutamol may be useful in the treatment of cardiogenic shock and pump failure complicating acute myocardial infarction." | 1.26 | Salbutamol in cardiogenic shock complicating acute myocardial infarction. ( Dawson, JR; Poole-Wilson, PA; Sutton, GC, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (47.62) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Puri, R | 2 |
| Nicholls, SJ | 2 |
| Nissen, SE | 1 |
| Brennan, DM | 2 |
| Andrews, J | 2 |
| Liew, GY | 2 |
| Nelson, AJ | 2 |
| Carbone, A | 2 |
| Copus, B | 2 |
| Tuzcu, EM | 2 |
| Beltrame, JF | 2 |
| Worthley, SG | 2 |
| Worthley, MI | 2 |
| Kapadia, SR | 1 |
| Gold, DR | 1 |
| Zolli, JR | 1 |
| Makaryus, AN | 1 |
| Ferrua, S | 1 |
| Varbella, F | 1 |
| Conte, MR | 1 |
| Singh, S | 1 |
| Loke, YK | 1 |
| Furberg, CD | 1 |
| Fisher, AA | 1 |
| Davis, MW | 1 |
| McGill, DA | 1 |
| Cazzola, M | 1 |
| Matera, MG | 1 |
| Donner, CF | 1 |
| Tomcsányi, J | 1 |
| Somlói, M | 1 |
| Frész, T | 1 |
| Arabadzisz, H | 1 |
| Zsoldos, A | 1 |
| Vecsey, T | 1 |
| Deriaz-Chessex, S | 1 |
| Carron, P | 1 |
| Gachoud, D | 1 |
| Fournier, Y | 1 |
| Donzé, J | 1 |
| Monti, M | 1 |
| Achtari Jeanneret, L | 1 |
| Rossier, A | 1 |
| Moix, PA | 1 |
| Barras-Moret, AC | 1 |
| Wilson, P | 1 |
| Dawson, JR | 2 |
| Bayliss, J | 1 |
| Norell, MS | 1 |
| Canepa-Anson, R | 1 |
| Kuan, P | 1 |
| Reuben, S | 1 |
| Poole-Wilson, PA | 2 |
| Sutton, GC | 2 |
| Henderson, A | 1 |
| Fowler, MB | 2 |
| Timmis, AD | 3 |
| Crick, JP | 1 |
| Vincent, R | 1 |
| Chamberlain, DA | 3 |
| Santo, M | 1 |
| Sidi, Y | 1 |
| Pinkhas, Y | 1 |
| Vermes, E | 1 |
| Leroy, G | 1 |
| Halphen, C | 1 |
| Guyon, P | 1 |
| Labib, M | 1 |
| Stoltz, JP | 1 |
| Haïat, R | 1 |
| Szczeklik, A | 1 |
| Nizankowski, R | 1 |
| Mruk, J | 1 |
| Strak, SK | 1 |
| Shovlin, CL | 1 |
| Tam, FW | 1 |
| Beauvoir, C | 1 |
| Sissman, J | 1 |
| Tekeres, M | 1 |
| Mezey, B | 1 |
| Kellényi, L | 1 |
1 review available for albuterol and Cardiovascular Stroke
| Article | Year |
|---|---|
Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol | 2005 |
1 trial available for albuterol and Cardiovascular Stroke
| Article | Year |
|---|---|
Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic shock after acute myocardial infarction.
Topics: Aged; Albuterol; Cardiac Output; Catecholamines; Clinical Trials as Topic; Dobutamine; Female; Hemod | 1982 |
19 other studies available for albuterol and Cardiovascular Stroke
| Article | Year |
|---|---|
Coronary endothelium-dependent vasoreactivity and atheroma volume in subjects with stable, minimal angiographic disease versus non-ST-segment-elevation myocardial infarction: an intravascular ultrasound study.
Topics: Aged; Albuterol; Angina, Stable; Chi-Square Distribution; Coronary Angiography; Coronary Vessels; Do | 2013 |
Coronary atheroma composition and its association with segmental endothelial dysfunction in non-ST segment elevation myocardial infarction: novel insights with radiofrequency (iMAP) intravascular ultrasonography.
Topics: Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Cardiac Catheters; Coronary Artery Disease; Co | 2015 |
Increased use of beta-agonists leading to non-ST-segment elevation myocardial infarction in a patient with hemodynamically significant myocardial bridging.
Topics: Adrenergic beta-Agonists; Albuterol; Asthma; Coronary Angiography; Coronary Vessel Anomalies; Electr | 2008 |
Images in cardiology. Acute myocardial infarction due to coronary vasospasm and salbutamol abuse.
Topics: Adult; Albuterol; Asthma; Bronchodilator Agents; Coronary Vasospasm; Female; Humans; Myocardial Infa | 2009 |
Outpatient management of severe COPD.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Drug Therapy, Combination; Humans; Myo | 2010 |
Acute myocardial infarction associated with albuterol.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Albuterol; Dose-Response Relationship, Drug; Elec | 2004 |
[Acute myocardial infarction triggered by salbutamol in asthma bronchiale].
Topics: Adrenergic beta-Agonists; Aged; Albuterol; Asthma; Bronchodilator Agents; Electrocardiography; Femal | 2006 |
[Highlights 2007 in hospital-based internal medicine: the point of view from the chief residents].
Topics: Accidental Falls; Aged; Albuterol; Anemia; Anticoagulants; Antidiuretic Hormone Receptor Antagonists | 2008 |
Clinical studies with beta 2 adrenoceptor agonists in heart failure.
Topics: Adrenergic beta-Agonists; Albuterol; Aminopyridines; Amrinone; Cardiotonic Agents; Ethanolamines; He | 1982 |
Recovery from cardiogenic shock complicating right ventricular myocardial infarction.
Topics: Albuterol; Dextrans; Dopamine; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic | 1983 |
Synergistic effects of a combined salbutamol-nitroprusside regimen in acute myocardial infarction and severe left ventricular failure.
Topics: Aged; Albuterol; Blood Pressure; Cardiac Output; Drug Synergism; Drug Therapy, Combination; Female; | 1980 |
Salbutamol in cardiogenic shock complicating acute myocardial infarction.
Topics: Aged; Albuterol; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Card | 1980 |
Acute myocardial infarction following intravenous salbutamol.
Topics: Albuterol; Asthma; Humans; Male; Middle Aged; Myocardial Infarction | 1980 |
[Myocardial infarction in a pregnant woman during salbutamol therapy].
Topics: Abortion, Threatened; Adult; Albuterol; Coronary Angiography; Electrocardiography; Female; Humans; M | 1997 |
Myocardial infarction in status asthmaticus.
Topics: Albuterol; Aminophylline; Asthma; Female; Humans; Middle Aged; Myocardial Infarction | 1977 |
Haemodynamic effects of salbutamol in patients with acute myocardial infarction and severe left ventricular dysfunction.
Topics: Adult; Aged; Albuterol; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarctio | 1979 |
Salbutamol nebuliser and precipitation of critical cardiac ischaemia.
Topics: Acute Disease; Albuterol; Asthma; Coronary Disease; Humans; Male; Middle Aged; Myocardial Infarction | 1990 |
[Asymptomatic electrical myocardial necrosis during the infusion of betamimetics in status asthmaticus].
Topics: Albuterol; Asthma; Cardiomyopathy, Dilated; Electrocardiography; Female; Humans; Middle Aged; Myocar | 1988 |
Effect of beta receptor-stimulating drugs on the cardiovascular and respiratory function of critically ill patients with serious heart disorders.
Topics: Albuterol; Arrhythmias, Cardiac; Asthma; Blood Pressure; Cardiovascular System; Female; Heart; Heart | 1974 |